Valeritas Holdings Inc (NASDAQ:VLRX)’s share price gapped down before the market opened on Tuesday . The stock had previously closed at $0.11, but opened at $0.36. Valeritas shares last traded at $0.34, with a volume of 37,363 shares.
Several research analysts recently weighed in on the stock. ValuEngine lowered shares of Valeritas from a “buy” rating to a “hold” rating in a research note on Saturday, December 21st. Oppenheimer downgraded shares of Valeritas from an “outperform” rating to a “market perform” rating in a report on Monday, December 23rd. Zacks Investment Research upgraded shares of Valeritas from a “sell” rating to a “hold” rating in a report on Thursday, February 6th. Finally, BTIG Research downgraded shares of Valeritas from a “buy” rating to a “neutral” rating in a report on Monday, December 23rd.
The company has a debt-to-equity ratio of 1.74, a quick ratio of 1.63 and a current ratio of 2.08. The stock has a market capitalization of $2.76 million, a price-to-earnings ratio of -0.03 and a beta of 1.72. The firm’s fifty day simple moving average is $0.64 and its 200 day simple moving average is $1.45.
Valeritas (NASDAQ:VLRX) last announced its earnings results on Tuesday, November 12th. The company reported ($1.91) EPS for the quarter, topping the consensus estimate of ($2.52) by $0.61. The firm had revenue of $8.46 million for the quarter. Valeritas had a negative net margin of 183.82% and a negative return on equity of 1,142.30%. Analysts forecast that Valeritas Holdings Inc will post -9.49 earnings per share for the current year.
In other Valeritas news, major shareholder Armistice Capital, Llc sold 1,060,000 shares of the firm’s stock in a transaction that occurred on Friday, December 20th. The shares were sold at an average price of $0.75, for a total transaction of $795,000.00. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Company insiders own 1.02% of the company’s stock.
Several hedge funds and other institutional investors have recently bought and sold shares of VLRX. Bank of New York Mellon Corp acquired a new stake in shares of Valeritas in the second quarter valued at approximately $68,000. Millennium Management LLC acquired a new stake in shares of Valeritas in the third quarter valued at approximately $77,000. Finally, Wedbush Securities Inc. raised its holdings in shares of Valeritas by 449.1% in the fourth quarter. Wedbush Securities Inc. now owns 90,000 shares of the company’s stock valued at $52,000 after purchasing an additional 73,609 shares during the last quarter. Institutional investors own 18.18% of the company’s stock.
About Valeritas (NASDAQ:VLRX)
Valeritas Holdings, Inc, a commercial-stage medical technology company, focuses on the development and commercialization of technologies to treat patients with Type 2 diabetes in the United States. The company offers V-Go, a wearable insulin delivery device for basal-bolus therapy. It also develops V-Go Prefill that is in the design-development stage for eliminating the device-filling process and the need for EZ fill refrigeration for patients with Type 2 diabetes; and V-Go SIM for real-time tracking information of basal and bolus dosing utilization.
Further Reading: Different Types of Derivatives
Receive News & Ratings for Valeritas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeritas and related companies with MarketBeat.com's FREE daily email newsletter.